Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 13/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 2/20 | 0.35 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29880662 | 0.88 | NR1H4 (0.70) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL273070 | 0.88 | NR1H4 (0.70) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL4524901 | 0.82 | NR1H4 (0.54) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL688553 | 0.74 | NR1H4 (0.60) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL689125 | 0.73 | NR1H4 (0.62) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL273529 | 0.72 | NR1H4 (1.00) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL29880856 | 0.72 | NR1H4 (1.00) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL718838 | 0.70 | NR1H4 (0.64) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL16917651 | 0.69 | NR1H4 (0.74) | NR1H4ESR1NR3C1PGRNR3C2 | |
| SCHEMBL274281 | 0.69 | ALDH1A1 (0.46) | NR1H4PKMELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1532153-B1 | AZEPINOINDOLE AND PYRIDOINDOLE DERIVATIVES AS PHARMACEUTICAL AGENTS | X CEPTOR THERAPEUTICS INC (US) | 2012-02-29 | — | — | EP | claimed |